Revelation Biosciences, Inc. Profile Avatar - Palmy Investing

Revelation Biosciences, Inc.

Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. The company engages in developing therapeutic product candidates, including REVTx-99…

Biotechnology
US, San Diego [HQ]
Major Shareholders · Proxy Ben. Owners

Shareholders

Breakdown
Revelation Biosciences, Inc. can't present any analysts estimates at the moment detail analysis.
Intraday
Shares Outstanding
8,356,500
Volume
311,922
Volume on Avg.
3,187,721
Beneficial Owners Beta
SEC Source
Owner Shares Equivalence - $0.49 per share Last Form/Filing Last Transaction
10% Holder
- No data -
Officers/Directors Below 10%
- No data -
End of REVB's Analysis
CIK: - CUSIP: 76135L101 ISIN: US76135L5075 LEI: - UEI: -
Secondary Listings
REVB has no secondary listings inside our databases.